盤(pan)(pan)龍(long)藥業近期(qi)披露投資者(zhe)(zhe)關(guan)系(xi)活動(dong)記錄表顯示(shi)，公(gong)司主(zhu)導產品盤(pan)(pan)龍(long)七片為(wei)風濕(shi)骨(gu)(gu)(gu)科類的(de)(de)(de)國家醫保甲(jia)類藥品，主(zhu)要(yao)目標為(wei)中老年人群，且可用(yong)于治(zhi)療膝(xi)骨(gu)(gu)(gu)關(guan)節炎、類風濕(shi)關(guan)節炎、強(qiang)直性(xing)脊柱炎等慢病治(zhi)療，可以顯著改善患者(zhe)(zhe)的(de)(de)(de)關(guan)節疼痛(tong)腫脹，是治(zhi)療風寒濕(shi)熱、風濕(shi)骨(gu)(gu)(gu)傷疾病的(de)(de)(de)推薦(jian)用(yong)藥。同時，公(gong)司近兩(liang)年增(zeng)速較(jiao)快的(de)(de)(de)產品骨(gu)(gu)(gu)松(song)寶(bao)片治(zhi)療骨(gu)(gu)(gu)折骨(gu)(gu)(gu)痛(tong)，預防骨(gu)(gu)(gu)質疏松(song)，適宜慢性(xing)骨(gu)(gu)(gu)病患者(zhe)(zhe)長期(qi)服用(yong)，相關(guan)產品也將(jiang)伴隨未來市(shi)場的(de)(de)(de)需求進(jin)一步增(zeng)長。（界(jie)面）